Lozada, Princess .

HRN: 28-66-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
AMPICILLIN 500MG (VIAL)
08/07/2026
08/07/2026
IVTT
350mg
Q6h
PCAP
Remove - Pending Acceptance
08/07/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
08/07/2026
08/14/2026
IV
25mg
Q8hrs
Impetigo
Remove - Pending Acceptance
08/07/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/07/2026
08/14/2026
TOPICAL
2mm
BID
Impetigo
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: